NYSE:STEMedical Equipment
Why STERIS (STE) Raised Its 2026 Revenue Guidance and What a CFO Transition Could Mean
STERIS plc recently reported first quarter results for the period ended June 30, 2025, showing year-over-year growth in sales to US$1.39 billion and net income to US$177.4 million, while also announcing a leadership transition with Karen L. Burton succeeding Michael J. Tokich as CFO effective August 18, 2025.
Alongside these results, STERIS raised its fiscal 2026 revenue growth guidance due to favorable foreign currency impacts, keeping its organic revenue expectations unchanged.
We'll...